5Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron, 2002, 33(3):341-355
6Choe LH, Dutt M J, Relkin N, et al. Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease.Electrophoresis, 2002, 23(14):2247-2251
7Aisen PS, Schafer KA, Grundman M, et al. For the Alzheimer's disease cooperative study. Effects of rofecoxib or naproxen vs placebo on Alzheimer's disease progression, a randomized controlled trial. JAMA, 2003, 289(21):2819-2826
8Wolozin B,Kellman W,Ruosseau P,et al.Decreased prevalence of Alzheimer's disease,associated with HMGCoA reductase inhibitors.Archives Neurol,2000,57:1439-1443